Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 6, 2025 / Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail Partners, LLC...
Pharmaceutical
Pharmacovigilance Market to Reach $26.2 billion, Globally, by 2034 at 12.3% CAGR: Allied Market Research
Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role...
PhaseV Earns Three Prestigious Industry Awards Highlighting Leadership in AI for Clinical Development
Company Included in CB Insights' Digital Health 50 List, TechCrunch's AI Disruptors 60 List and Named BioTech Breakthrough 'Analytics Solution...
Evogene Schedules Third Quarter 2025 Financial Results Release
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd....
Verseon’s Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences
One paper presented at IEEE International Conference on Future Machine Learning and Data Science 2025 covers Verseon's superior predictions of...
Using Early Real-world Evidence Generation to Drive Commercial Success, Upcoming Webinar with Sciensus, Hosted by Xtalks
In this free webinar, explore the strategic value of early real-world evidence generation in biotech development, focusing on what data...
Enhance Peptide Manufacturing Using Backbone N-Protecting Groups, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn backbone protecting group strategies for overcoming difficulties during solid-phase peptide synthesis and solution-phase handling. The...
Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients
Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in...
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
DOVER, Del., Nov. 6, 2025 /PRNewswire/ --Â Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies...
World Series Spotlights Need for Wearable Ultrasound System to Accelerate Recovery, Treat Injuries
Sustained acoustic medicine from ZetrOZ Systems supports recovery when players face intense physical demands, such as an 18-inning game. TRUMBULL,...
The Longevity Center FL Explores the Benefits of EBOO Therapy for Oxygenating and Detoxifying the Blood
An evidence-based look at a modern therapy advancing wellness and regenerative medicine WEST PALM BEACH, FLORIDA / ACCESS Newswire /...
Medical Care Technologies (OTC Pink:MDCE) Enters Final Phase of Testing for First Consumer App, With Beta Launch Slated for Q4 2025
MESA, ARIZONA / ACCESS Newswire / November 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall...
Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health’s Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health’s Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...